SEC Form 4 · accession 0001246360-17-000626
NxStage Medical, Inc. · NXTM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey H Burbank
Officer — Chief Executive Officer · Director
Period of report
Feb 10, 2017
Accepted (ET)
Feb 14, 2017 · 5:34 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001333170
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 10, 2017 | M | 123,900 | $9.96 | A | 991,516 | D | |
| Common Stock | Feb 10, 2017 | M | 3,697 | $18.48 | A | 995,213 | D | |
| Common Stock | Feb 10, 2017 | M | 5,591 | $18.59 | A | 1,000,804 | D | |
| Common Stock | Feb 10, 2017 | F | 49,555 | $28.38 | D | 951,249 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $9.96 | Feb 10, 2017 | M | 123,900 | D | Apr 3, 2010 | Mar 2, 2017 | Common Stock | 123,900 | 0 | D |
| Stock Option (Right to Buy) | $18.48 | Feb 10, 2017 | M | 3,697 | D | Apr 9, 2012 | Mar 8, 2019 | Common Stock | 3,697 | 39,062 | D |
| Stock Option (Right to Buy) | $18.59 | Feb 10, 2017 | M | 5,591 | D | Jun 27, 2011 | May 26, 2018 | Common Stock | 5,591 | 36,273 | D |